Allogene Therapeutics, Inc. ALLO
0.63 USD -0.04 (-5.88%)
Regular-session close
0.63 +0.01 +1.12%
After hours · Nov 20, 7:37 PM ET
0.6192 Day range 0.67
0.6277 52-week range 3.06
- YTD
- -54.18%
- 1 year
- -49.38%
ALLO revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | -22,000 | -100.00% |
| FY 2024 | 2024-12-31 | 22,000 | -73,000 | -76.84% |
| FY 2023 | 2023-12-31 | 95,000 | -61,000 | -39.10% |
| FY 2022 | 2022-12-31 | 156,000 | -113,933,000 | -99.86% |
| FY 2021 | 2021-12-31 | 114,089,000 | 114,089,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:39.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
